US · Healthcare · Health Information Services
EPS came in at 0.26 against a street estimate of 0.28 — a miss of 7.1%.
Analysts rate Doximity Inc a buy (8 buy, 11 hold, 0 sell out of 19) with an average price target of $24.61.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.82% |
| Vanguard Portfolio Management, LLC | 3.51% |
| Vanguard Capital Management, LLC | 3.16% |
| ClearBridge Advisors, LLC | 2.73% |
| William Blair Investment Management, LLC | 2.65% |
| Carmignac Gestion | 2.36% |
| State Street Corp | 2.22% |
| Geode Capital Management, LLC | 2.16% |
| Document | Date |
|---|---|
| Proxy statement · Q3 2026 | 2026-07-15 |
| Annual report FY2026 | 2026-05-19 |
| Results announced · Q2 2026 | 2026-05-13 |
| Board / officer change · Q2 2026 | 2026-04-17 |
| Quarterly report · Q4 2025 | 2026-02-05 |
| Results announced · Q1 2026 | 2026-02-05 |
| Company announcement · Q4 2025 | 2025-12-30 |
| Quarterly report · Q3 2025 | 2025-11-06 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Doximity Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.